FDA-Inspected Site

Sarah H. Lisanby, M.D.

2 FDA inspections are on record for Sarah H. Lisanby, M.D. in New York, United States.

483· Form 483 issued

New York, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2012-10-29.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
29 Oct 2012Not recorded483View 483 →
9 Jun 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

29 Oct 2012
21 CFR 812.43(c)

No investigator agreement

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.43(c)(1)

No curriculum vitae in investigator agreement

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.100

Investigator lack of informed consent

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.100

Investigator non-compliance with agreement/plan/regulations

Cited by Eileen J Bannerman

29 Oct 2012
21 CFR 812.140(a)(4)

Investigator protocol records inadequate

Cited by Eileen J Bannerman

Investigators

FDA investigators tied to this site in the record.

Alia Legaux1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 812.100Cited across public-safe Form 483 observations2x
21 CFR 812.140(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 812.140(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 812.43(c)Cited across public-safe Form 483 observations1x
21 CFR 812.43(c)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Sarah H. Lisanby, M.D.'s 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat